Adagene Inc. (ADAG) intrinsic value & 10-year financials

Adagene Inc. (ADAG) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 9 fiscal years revenue grew 26.1% a year to $7.7M, with an average return on invested capital of 96.9%.

Graham intrinsic value
—
Revenue (FY2025)
$7.7M
Revenue growth (9-yr CAGR)
26.1%
ROIC (10-yr avg)
96.9%
Free cash flow (FY2025)
-$15.7M

ADAG 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $7.7M -$17.6M -$0.30 -$15.7M -279.5% 72.1%
FY2024 $103.2K -$33.4M -$0.59 -$29.7M -34835.4% 168.4%
FY2023 $18.1M -$18.9M -$0.35 -$28.5M -131.0% 72.9%
FY2022 $9.3M -$80.0M -$1.48 -$49.3M -903.1% 294.0%
FY2021 $10.2M -$73.2M -$1.46 -$45.9M -711.2% 83.2%
FY2020 $700.9K -$42.4M -$0.89 -$29.5M -6156.5% 27.5%
FY2019 $480.0K -$16.4M -$0.37 -$18.3M -3993.7% 11.1%
FY2018 $1.5M -$15.3M -$0.31 -$14.8M -1147.1% 45.8%
FY2017 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Adagene Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Adagene Inc. has earned high returns on invested capital, averaging 39.7% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Adagene Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Adagene Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-9.96 per share.

ADAG stock: frequently asked questions

What is the intrinsic value of Adagene Inc. (ADAG) stock?

Graham's formula only works with positive earnings. Adagene Inc. reported diluted EPS of -$0.30 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Adagene Inc. generate free cash flow?

Adagene Inc. generated -$15.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 8 reported years.

What is ADAG's return on invested capital?

Average ROIC over the last 9 fiscal years was 96.9%, and average return on equity was -33.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ADAG data come from?

From Adagene Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Apr 1, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks